Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?

#2022
#Cancers

PMU Autor*innen
Gundula Rendl, Gregor Schweighofer-Zwink, Wolfgang Hitzl, Christian Pirich

Alle Autor*innen
Gundula Rendl, Gregor Schweighofer-Zwink, Stefan Sorko, Hans-Jürgen Gallowitsch, Wolfgang Hitzl, Diana Reisinger, Christian Pirich

Fachzeitschrift
Cancers

Kurzfassung

Keywords

MANAGEMENT, DOUBLE-BLIND, PARAMETERS, SOLID TUMORS, METASTASES, CARCINOMA, TYROSINE KINASE INHIBITORS, EMISSION-TOMOGRAPHY, PROGNOSTIC VALUE, SORAFENIB